Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single‐cell transcriptomics

Virtually all patients with multiple myeloma become unresponsive to treatment over time. Relapsed/refractory multiple myeloma (RRMM) is accompanied by the clonal evolution of myeloma cells with heterogeneous genomic aberrations and profound changes of the bone marrow microenvironment (BME). However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Tirier, Stephan M., Mallm, Jan-Philipp, Steiger, Simon, Poos, Alexandra M., Awwad, Mohamed H. S., Giesen, Nicola, Casiraghi, Nicola, Susak, Hana, Bauer, Katharina, Baumann, Anja, John, Lukas, Seckinger, Anja, Hose, Dirk, Müller-Tidow, Carsten, Goldschmidt, Hartmut, Stegle, Oliver, Hundemer, Michael, Weinhold, Niels, Raab, Marc S., Rippe, Karsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630108/
https://www.ncbi.nlm.nih.gov/pubmed/34845188
http://dx.doi.org/10.1038/s41467-021-26951-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630108/
https://www.ncbi.nlm.nih.gov/pubmed/34845188
http://dx.doi.org/10.1038/s41467-021-26951-z

Ejemplares similares